Posted by Michael Wonder on 14 Aug 2018
Call for Pharmaceutical Benefits Scheme to include subsidies for more rare cancer treatments
14 August 2018 - Oncologists say thousands of cancer patients are either missing out on medication or being forced to spend large portions of their savings on potentially life-saving treatments because of gaps in the Pharmaceutical Benefits Scheme.
That's why the National Oncology Alliance is calling on the PBAC to subsidise more rare cancer treatments.
Queensland man Colin White was given just several months to live after being diagnosed with a rare small cell carcinoma of the lymph gland.
